beta

EGLT

Egalet Corporation

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Egalet Corp is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and in other indications.

Market Cap: 42.7 Million

Primary Exchange: NASDAQ Global Market

Website:

Shares Outstanding: 45.9 Million

Float: 45.4 Million

Dividend: 0.0 (0.0%)

Beta: 0.30023

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1173 trading days

From: 2014-03-10 To: 2018-09-18

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud